McDermott + Bull Partner Ken Dropiewski talks with Gilde Healthcare General Partner Geoff Pardo about what his team looks for in prospective partners in new venture opportunities.
Interviews/Contributions
Investor Insights: Geoff Pardo – How Do You See Venture in MedTech Looking In 2023? (Part 1)
McDermott + Bull Partner Ken Dropiewski talks with Gilde Healthcare General Partner Geoff Pardo about what he’s expecting to see in the venture capital space in 2023.
Investor Insights: Rob Barmann – Non-Traditional MedTech Services (Part 5)
McDermott + Bull Partner Ken Dropiewski interviews Endeavour Venture Partner Rob Barmann in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Rob discuss a range of topics from typical investment sizes to non-traditional MedTech services.
Investor Insights: Rob Barmann – What is Your Typical Investment Size? (Part 4)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about typical investment sizes in their portfolio companies.
Investor Insights: Rob Barmann – How Do You See Venture in MedTech Looking In 2023? (Part 3)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about what he’s expecting to see in the venture capital space in 2023.
Investor Insights: Rob Barmann – What Do You Look for in New MedTech Ventures? (Part 2)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about what his team looks for in prospective partners in new venture opportunities.
Investor Insights: Rob Barmann – Transitioning from Corporate Development to Venture Capital (Part 1)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about his journey from corporate development to venture capital.
Investor Insights: Sabir Rassiwalla – What Can We Expect From CRG in the Future? (Part 3)
McDermott + Bull Partner Ken Dropiewski talks with CRG Director Sabir Rassiwalla about what drove him to CRG after a long tenure with Abbott.
Investor Insights: Sabir Rassiwalla – What Makes CRG Different From Other Healthcare Investors? (Part 2)
McDermott + Bull Partner Ken Dropiewski talks with CRG Director Sabir Rassiwalla about how CRG is different from healthcare investment partners in the market.
Investor Insights: Sabir Rassiwalla – How Has MedTech’s Changing Landscape Brought You to CRG? (Part 1)
McDermott + Bull Partner Ken Dropiewski talks with CRG Director Sabir Rassiwalla about what drove him to CRG after a long tenure with Abbott.
Recent
Popular
- No commented posts yet